Table 1.
Comparison of neuroimaging techniques used in various neuromuscular disorders.
| Neuromuscular diseases | Technique |
|||||
|---|---|---|---|---|---|---|
| CT | MRI | fMRI | SPECT | PET | TCS | |
| Dystroglycanopathies | + | ++ | − | − | − | − |
| Congenital muscular dystrophies | + | ++ | − | − | − | − |
| Myotonic dystrophy type 1 | + | ++ | ++ | ++ | ++ | + |
| Myotonic dystrophy type 2 | + | ++ | + | + | + | + |
| Dystrophinopathies | ++ | ++ | + | + | + | − |
| Glycogenosis disease type II | + | + | + | − | − | − |
| Oculopharyngeal muscular dystrophy | − | − | − | − | − | − |
| Facioscapulohumeral dystrophy | ± | + | − | − | − | − |
Changes: −, not described or reported; ±, slight brain changes; +, significant brain changes; ++, marked structural or functional abnormality.
CT, computerized tomography; fMRI, functional MRI; MRI, magnetic resonance imaging; PET, positron emission tomography; SPECT, single photon emission computed tomography; TCS, transcranial sonography.